UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

Date of Report (date of earliest event reported): April 7, 2014

MIMEDX GROUP, INC.
(Exact name of registrant as specified in charter)

Florida
000-52491
26-2792552
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

1775 West Oak Commons Ct, NE
 
30062
Marietta, GA
 
(Zip Code)
(Address of principal executive offices)
 
 

(770) 651-9100
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Item 2.02 Results of Operations and Financial Conditions.

On April 7, 2014, MiMedx Group, Inc. (the “Company”) issued a press release announcing its first quarter of 2014 revenue slightly exceeded the upper end of its previously announced guidance.  The release also announced its guidance for the second quarter of 2014.  A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information provided pursuant to this Item 2.02 is to be considered “furnished” pursuant to Item 2.02 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference into any of the Company’s reports or filings with the Securities and Exchange Commission, whether made before or after the date hereof, except as expressly set forth by specific reference in such report or filing.
  
Exhibit No.
 
Description
 
 
 
 
MiMedx Group, Inc. Press Release, dated April 7, 2014
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 7, 2014
MIMEDX GROUP, INC.
 
 
 
 
 
By:
/s/: Michael J. Senken
 
 
 
Michael J. Senken, Chief Financial Officer
 
 
 
2